Multi-Pathway Skin Inflammation Treatment Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current skin care products often fail to effectively address skin inflammation due to their inability to inhibit multiple reactive pathways that contribute to inflammation, leading to suboptimal skin normalization.
Innovation Solution
A method of formulating compositions that identifies and inhibits multiple pathways contributing to skin inflammation, such as the Adhesion, Chemotaxis, COX, and Histamine pathways, by selecting specific ingredients that target these pathways and combining them into a topical composition for application.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current skin care products use single-ingredient or simple formulations, then manufacturing is simple and cost-effective, but they cannot effectively inhibit multiple reactive pathways contributing to skin inflammation
Solution Approach 1:
The invention segments the approach to skin inflammation by targeting multiple distinct reactive pathways (COX, LO, PLA2, Histamine, Adhesion, Chemotaxis) with specific pathway-inhibiting ingredients rather than using a single broad-spectrum ingredient. This segmentation allows each ingredient to address specific inflammatory mechanisms, improving overall effectiveness while maintaining manageable formulation complexity through systematic organization.
Solution Approach 2:
The invention applies multi-functionality by creating a skin care composition that simultaneously inhibits multiple reactive pathways through a combination of ingredients. Each ingredient is selected for its ability to target specific pathways, and the collective formulation addresses various aspects of skin inflammation, normalization, and repair in a single multi-functional product system.
2Reliability
If skin care products contain multiple ingredients targeting different pathways, then skin normalization effectiveness improves, but formulation and selection process becomes more complex
Solution Approach 1:
The invention employs parameter changes by systematically varying the concentration ranges and selection criteria of ingredients based on their specific pathway-inhibiting properties. By establishing specific concentration parameters for different ingredient classes (e.g., COX inhibitors, PLA2 inhibitors, Histamine inhibitors), the formulation process becomes more streamlined and manufacturable while maintaining comprehensive pathway coverage.
3Adaptability or versatility
If existing products target only a few inflammatory pathways, then formulation remains simple, but they fail to address the myriad of biological reactive pathways contributing to skin inflammation
Solution Approach 1:
The invention segments the inflammatory pathways into distinct categories (COX, LO, PLA2, Histamine, Adhesion, Chemotaxis) and selects ingredients that specifically target each segment. This segmentation enables comprehensive coverage of multiple pathways while organizing the ingredient list in a systematic manner that manages complexity through structured classification.
Solution Approach 2:
The invention uses composite materials by combining multiple ingredients with different pathway-inhibiting properties into a single skin care composition. This composite formulation integrates COX inhibitors, LO inhibitors, PLA2 inhibitors, Histamine inhibitors, and other pathway-targeting agents to create a synergistic system that addresses the full spectrum of skin inflammation mechanisms.
Data Source
AI summary
A method for treating intact irritated or inflamed skin with a composition comprising at least one Histamine Receptor pathway inhibitor; at least one Lipoxygenase pathway inhibitor; at least one Cyclooxygenase pathway inhibitor and at least one Chemotaxis pathway inhibitor.